The drugmaker’s stock checks all the boxes for a split. the price keeps climbing, the company is on fire, and it’s a bull ...

Eli Lilly and Company (NYSE: LLY) is one of the 15 Best Aggressive Growth Stocks to Buy Right Now. On November 7, TD Cowen ...

Let’s delve into the details of each of the evaluated factors, but first, for a quick background: With a $917 Bil market cap, ...

Eli Lilly's $2.6 billion agreement with ABL Bio focuses on developing therapeutics using the Grabody Platform for bispecific ...

Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Eli Lilly shares have room to keep going as GLP-1 drugs spread their reach.

Eli Lilly stock has regained all-time highs, outpacing rivals in the obesity drug market. Click here to read my latest ...

South Korea’s newest billionaire is Lee Sang-hoon, founder of ABL Bio, after it struck a $2.6 billion licensing and joint ...

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

Eli Lilly receives CDSCO approval for donanemab, a new Alzheimer's treatment targeting early symptomatic stages of the ...